All News

A higher complete response rate was seen in patients given both agents compared with those given Imbruvica alone.

Survivors teach medical and nursing students around the world about early disease signs and symptoms.

How a young boy on chemo marked the days until the end of his treatments.

The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Tecentriq (atezolizumab) to be used in combination with Avastin (bevacizumab), carboplatin and paclitaxel for the first-line treatment of patients with metastatic nonsquamous non–small cell lung cancer (NSCLC).

The treatment landscape of mantle cell lymphoma is continuing to change. See what expert Andre Goy, M.D., has to say about it.

Keeping a healthy weight is vital for everyone, especially breast cancer survivors.

A guy with breast cancer reveals a secret that can save your life.

A look back on that time more than 200 men grabbed their balls in public.

The Food and Drug Administration (FDA) approved the two-drug combination Tafinlar (dabrafenib) and Mekinist (trametinib) to treat patients with metastatic or unresectable anaplastic thyroid cancer (ATC), whose tumors harbor the BRAF V600E mutation.

Immunotherapy is making landmark change in the treatment of patients with genitourinary (GU) cancers, with bladder cancer being the pioneer in the field, having five FDA-approved checkpoint inhibitors. But kidney cancer is not far behind, with a breakthrough therapy designation granted for a Keytruda (pembrolizumab) combination this past January.

How a clown named Miss Sydney helped so many kids battling cancer.

Saying goodbye to your old normal is necessary when you're faced with cancer. The new normal is a vitally important part of a cancer survivor's post diagnosis timeline.

Girls Gone Rx sponsors all-female fitness competitions to raise money for Bright Pink, a nonprofit that focuses on prevention and early detection of breast and ovarian cancer.

Palliative care can be used at all cancer stages, and can drastically improve patients' quality of life.

I've been a survivor for over a year, but I always say, "I am surviving." Why?

As suspected, the average early mortality rate improved overall during the study period. But while evaluating the data, researchers noticed something interesting about the difference in early mortality at the NCI-designated cancer centers compared to non-NCI-designated cancer centers.

A musician with breast cancer reflects on the power of music in our health and healing.

It may take some time, but finding the right oncologist can be like striking gold.

After radiation, as the skin heals, a compassionate dermatologist can help us to monitor any lingering side-effects.

Alternative cancer treatment takes a moderate amount of effort, but this survivor thinks it's worth it.

One expert discusses current standard-of-care regimens as well as new combinations on the horizon for patients with myeloma who are not eligible to receive a stem cell transplant.

With the number of treatment options consistently increasing, tumor testing is growing more important to personalize care for women with ovarian cancer.

The Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) – a CAR-T cell therapy – for the treatment of adult patients who have relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have relapsed or are ineligible for an autologous stem cell transplant (ASCT).

Admission is by invitation only and the dues are high. Once we're in, we're members for life.

Breast cancer survivor tries to decide if she is spoiled and ungrateful or, if like many cancer survivors, she just needs a little safety valve to blow off steam.

An evening of storytelling among women afflicted by ovarian cancer – whether it be their own diagnosis or a loved one’s – helped to empower individuals to find their voice.

Perspective is important with cancer and remission.

Don't be scared to write "legacy letters." Here's advice on getting started and why it matters from a woman with metastatic breast cancer